Dwarf open reading frame (DWORF) is a direct activator of the sarcoplasmic reticulum calcium pump SERCA

Abstract

The sarcoplasmic reticulum calcium pump SERCA plays a critical role in the contraction-relaxation cycle of muscle. In cardiac muscle, SERCA is regulated by the inhibitor phospholamban. A new regulator, dwarf open reading frame (DWORF), has been reported to displace phospholamban from SERCA. Here, we show that DWORF is a direct activator of SERCA, increasing its turnover rate in the absence of phospholamban. Measurement of in-cell calcium dynamics supports this observation and demonstrates that DWORF increases SERCA-dependent calcium reuptake. These functional observations reveal opposing effects of DWORF activation and phospholamban inhibition of SERCA. To gain mechanistic insight into SERCA activation, fluorescence resonance energy transfer experiments revealed that DWORF has a higher affinity for SERCA in the presence of calcium. Molecular modeling and molecular dynamics simulations provide a model for DWORF activation of SERCA, where DWORF modulates the membrane bilayer and stabilizes the conformations of SERCA that predominate during elevated cytosolic calcium.

Data availability

All data generated or analyzed during this study are included in the manuscript.

Article and author information

Author details

  1. M'Lynn E Fisher

    Biochemistry, University of Alberta, Edmonton, Canada
    Competing interests
    No competing interests declared.
  2. Elisa Bovo

    Department of Cell and Molecular Physiology, Loyola University Chicago, Chicago, United States
    Competing interests
    No competing interests declared.
  3. Rodrigo Aguayo-Ortiz

    Internal Medicine, University of Michigan, Ann Arbor, United States
    Competing interests
    No competing interests declared.
  4. Ellen E Cho

    Department of Cell and Molecular Physiology, Loyola University Chicago, Maywood, United States
    Competing interests
    No competing interests declared.
  5. Marsha P Pribadi

    Department of Cell and Molecular Physiology, Loyola University Chicago, Chicago, United States
    Competing interests
    No competing interests declared.
  6. Michael P Dalton

    Department of Cell and Molecular Physiology, Loyola University Chicago, Chicago, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-5296-5099
  7. Nishadh Rathod

    Biochemistry, University of Alberta, Edmonton, Canada
    Competing interests
    No competing interests declared.
  8. M Joanne Lemieux

    Biochemistry, University of Alberta, Edmonton, Canada
    Competing interests
    M Joanne Lemieux, Reviewing editor, eLife.
  9. L Michel Espinoza-Fonseca

    Internal Medicine, University of Michigan, Ann Arbor, United States
    Competing interests
    No competing interests declared.
  10. Seth L Robia

    Department of Cell and Molecular Physiology, Loyola University Chicago, Maywood, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-1193-9510
  11. Aleksey V Zima

    Department of Cell and Molecular Physiology, Loyola University Chicago, Chicago, United States
    Competing interests
    No competing interests declared.
  12. Howard S Young

    Biochemistry, University of Alberta, Edmonton, Canada
    For correspondence
    hyoung@ualberta.ca
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-5990-8422

Funding

National Institutes of Health (R01HL092321)

  • Seth L Robia

National Institutes of Health (R01HL092321)

  • Howard S Young

National Institutes of Health (R01HL143816)

  • Seth L Robia

National Institutes of Health (R01HL143816)

  • Howard S Young

National Institutes of Health (R01GM120142)

  • L Michel Espinoza-Fonseca

National Institutes of Health (R01HL148068)

  • L Michel Espinoza-Fonseca

National Institutes of Health (R01HL130231)

  • Aleksey V Zima

Natural Sciences and Engineering Research Council of Canada (RGPIN-2016-06478)

  • M Joanne Lemieux

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2021, Fisher et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,762
    views
  • 355
    downloads
  • 32
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. M'Lynn E Fisher
  2. Elisa Bovo
  3. Rodrigo Aguayo-Ortiz
  4. Ellen E Cho
  5. Marsha P Pribadi
  6. Michael P Dalton
  7. Nishadh Rathod
  8. M Joanne Lemieux
  9. L Michel Espinoza-Fonseca
  10. Seth L Robia
  11. Aleksey V Zima
  12. Howard S Young
(2021)
Dwarf open reading frame (DWORF) is a direct activator of the sarcoplasmic reticulum calcium pump SERCA
eLife 10:e65545.
https://doi.org/10.7554/eLife.65545

Share this article

https://doi.org/10.7554/eLife.65545

Further reading

    1. Biochemistry and Chemical Biology
    2. Genetics and Genomics
    Conor J Howard, Nathan S Abell ... Nathan B Lubock
    Research Article

    Deep Mutational Scanning (DMS) is an emerging method to systematically test the functional consequences of thousands of sequence changes to a protein target in a single experiment. Because of its utility in interpreting both human variant effects and protein structure-function relationships, it holds substantial promise to improve drug discovery and clinical development. However, applications in this domain require improved experimental and analytical methods. To address this need, we report novel DMS methods to precisely and quantitatively interrogate disease-relevant mechanisms, protein-ligand interactions, and assess predicted response to drug treatment. Using these methods, we performed a DMS of the melanocortin-4 receptor (MC4R), a G-protein-coupled receptor (GPCR) implicated in obesity and an active target of drug development efforts. We assessed the effects of >6600 single amino acid substitutions on MC4R’s function across 18 distinct experimental conditions, resulting in >20 million unique measurements. From this, we identified variants that have unique effects on MC4R-mediated Gαs- and Gαq-signaling pathways, which could be used to design drugs that selectively bias MC4R’s activity. We also identified pathogenic variants that are likely amenable to a corrector therapy. Finally, we functionally characterized structural relationships that distinguish the binding of peptide versus small molecule ligands, which could guide compound optimization. Collectively, these results demonstrate that DMS is a powerful method to empower drug discovery and development.

    1. Biochemistry and Chemical Biology
    Meina He, Yongxin Tao ... Wenli Chen
    Research Article

    Copper is an essential enzyme cofactor in bacteria, but excess copper is highly toxic. Bacteria can cope with copper stress by increasing copper resistance and initiating chemorepellent response. However, it remains unclear how bacteria coordinate chemotaxis and resistance to copper. By screening proteins that interacted with the chemotaxis kinase CheA, we identified a copper-binding repressor CsoR that interacted with CheA in Pseudomonas putida. CsoR interacted with the HPT (P1), Dimer (P3), and HATPase_c (P4) domains of CheA and inhibited CheA autophosphorylation, resulting in decreased chemotaxis. The copper-binding of CsoR weakened its interaction with CheA, which relieved the inhibition of chemotaxis by CsoR. In addition, CsoR bound to the promoter of copper-resistance genes to inhibit gene expression, and copper-binding released CsoR from the promoter, leading to increased gene expression and copper resistance. P. putida cells exhibited a chemorepellent response to copper in a CheA-dependent manner, and CsoR inhibited the chemorepellent response to copper. Besides, the CheA-CsoR interaction also existed in proteins from several other bacterial species. Our results revealed a mechanism by which bacteria coordinately regulated chemotaxis and resistance to copper by CsoR.